Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Received Clearance from U.S. FDA to Proceed with Global Registrational Phase III Clinical Trial for Lisaftoclax (APG-2575) in Previously Treated Patients with CLL/SLL 2023-08-07 09:43
Avance Clinical Earns Frost & Sullivan's 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data 2023-08-07 08:00
AI+ Media Development Platform AlfaOPA™ Officially Launched 2023-08-04 11:13
JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology 2023-08-03 17:13
SayHeart Announces AI-Powered Visual-to-Text Transformation Pilot Testing for Dental X-Rays, with Kindlehouse Dentistry Partnership 2023-08-03 12:40
Interest in Ayurvedic beauty surges, but 1 in 5 Indian consumers find it old-fashioned 2023-08-03 12:30
ESMO 2023 | Ascentage Pharma to Present Results from Two Clinical Studies, including One Oral Presentation, at 2023 ESMO Congress 2023-08-03 11:43
SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation 2023-08-03 07:30
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting 2023-08-03 07:00
Unlocking the Power of Genetics: Camtech Unveils DNA Self-Test Kits for Holistic Wellness 2023-08-02 14:42
Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023 2023-08-01 21:07
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System 2023-08-01 20:00
Doer Biologics Announces First Subject Dosed in Phase I 12-Week Multiple-Ascending Dose (MAD) Clinical Trial of DR10624 and Received IND Approval From NMPA 2023-08-01 17:08
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study 2023-08-01 08:47
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC 2023-08-01 00:00
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow 2023-07-31 17:59
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT) 2023-07-31 17:05
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density 2023-07-31 08:10
1 50 51 52 53 54 375